- -

The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Miri, Amir Hossein es_ES
dc.contributor.author Kamankesh, Mojtaba es_ES
dc.contributor.author Llopis-Lorente, Antoni es_ES
dc.contributor.author Liu, Chenguang es_ES
dc.contributor.author Wacker, Matthias G. es_ES
dc.contributor.author Haririan, Ismaeil es_ES
dc.contributor.author Asadzadeh Aghdaei, Hamid es_ES
dc.contributor.author Hamblin, Michael R. es_ES
dc.contributor.author Yadegar, Abbas es_ES
dc.contributor.author Rad-Malekshahi, Mazda es_ES
dc.contributor.author Zali, Mohammad Reza es_ES
dc.date.accessioned 2024-04-11T11:50:05Z
dc.date.available 2024-04-11T11:50:05Z
dc.date.issued 2022-06-27 es_ES
dc.identifier.uri http://hdl.handle.net/10251/203416
dc.description.abstract [EN] Helicobacter pylori (H. pylori) is a notorious, recalcitrant and silent germ, which can cause a variety of debilitating stomach diseases, including gastric and duodenal ulcers and gastric cancer. This microbe predominantly colonizes the mucosal layer of the human stomach and survives in the inhospitable gastric microenvironment, by adapting to this hostile milieu. In this review, we first discuss H. pylori colonization and invasion. Thereafter, we provide a survey of current curative options based on polypharmacy, looking at pharmacokinetics, pharmacodynamics and pharmaceutical microbiology concepts, in the battle against H. pylori infection. es_ES
dc.language Inglés es_ES
dc.publisher Frontiers Media SA es_ES
dc.relation.ispartof Frontiers in Pharmacology es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject H. pylori es_ES
dc.subject Antibiotic therapy es_ES
dc.subject Biopharmaceutical principles es_ES
dc.subject Pharmaceutical microbiology es_ES
dc.subject Pharmacodynamics es_ES
dc.subject Pharmacokinetics es_ES
dc.title The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3389/fphar.2022.917184 es_ES
dc.rights.accessRights Abierto es_ES
dc.description.bibliographicCitation Miri, AH.; Kamankesh, M.; Llopis-Lorente, A.; Liu, C.; Wacker, MG.; Haririan, I.; Asadzadeh Aghdaei, H.... (2022). The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Frontiers in Pharmacology. 13:1-16. https://doi.org/10.3389/fphar.2022.917184 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.3389/fphar.2022.917184 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 16 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 13 es_ES
dc.identifier.eissn 1663-9812 es_ES
dc.identifier.pmid 35833028 es_ES
dc.identifier.pmcid PMC9271669 es_ES
dc.relation.pasarela S\483993 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem